Intraoperative technological advances and new frontiers in precision glioma surgery - Takeaways - MDSpire

Intraoperative technological advances and new frontiers in precision glioma surgery

  • By

  • Christina Abi Faraj

  • Christopher C. Young

  • Thomas H. Beckham

  • Jeffrey S. Weinberg

  • July 4, 2026

  • 0 min

Share

  • 1

    Diffuse gliomas are the most common aggressive primary brain tumors in adults, with a 5-year survival rate of only 10% despite aggressive treatment.

  • 2

    Maximal safe surgical resection significantly improves progression-free and overall survival, with a minimum extent of resection of 70–78% suggested for survival advantage.

  • 3

    Supramarginal resection, which includes non-enhancing tumor areas, has been associated with improved overall survival compared to resection of only contrast-enhancing tumors.

  • 4

    Intraoperative technologies such as neuronavigation and functional mapping are developed to optimize extent of resection while preserving neurological function.

  • 5

    Local drug delivery strategies, like Gliadel® wafers, bypass the blood-brain barrier, allowing high concentrations of chemotherapy directly into the tumor resection cavity.

Original Source(s)

Related Content